Th~ purpose of thi~ stud~ "as to Ideotif) "'hleh of the bIochemical. immunological, or functional parameters deriled before suraer) IS part of • systemic enluation "ere helpful in predictin" the frequenc) of rejection episodes, the chance of survivII, and the cauSe risk of death (should death occur) of patients after orthotopic Unr transplantation (OL Tx). Ninet)-elaht Idult pltients "'ho had an extensive preoperltive protocol e'alultion "ere studied before OlTx. The biocbemical parameters assessed "ere albumin. prothrombin time, bilirubin. and ICG clearance. The immunologic parameters aswssed included totlll)mpbocytes. T3 cells, T4 cells. 1'8 cells, and the T4[T8 ratio. The dejT~ of histocompatibilit) anti"en (HlA) matching be"'een the donor and the recipient "as also evaluated In 80 of the 98 patients studied.
D
UE TO A \ARIETY of factors, such as better initial selection of candidates for the procedure. refinements in the techniques of organ procurement and surgical grafting, the introduction of cyc1osporine A (CyA). and improvements in the pre-and postoperative management of such patients, the life expectanc) of patients undergoing orthotopic liver transplantation (OL Tx) has increased considerabl)' over the last several years. I Recent data from our institution regarding sun;val sho .... a 69.7 and 62.8'l 1-and 5-year actuarial sun;val in 313 adult liver transplant patients.:
The vast majority of the postoperative deaths have occurred .... ;thin the first 2 postoperative months and are related primarily to sepsis. 3 Rejection is also a frequent. albeit controllable. problem after OL Tx.
The intensi"'e immunosuppressive regimens used to treat rejection facilitate postoperative sepsis Other factors, independent of the preoperative condition of the patient receiving a graft, might also play an imJX)rtant role in contributing to some of the postoperative deaths observed. Examples include ischemia of the graft and technical problems at the time of the operation that lead to postoperative vascular anastomotic thrombosis.
Because of these uncertainties, we have evaluated pa_ tients prospectively for liver transplant and have tried to identify immunologic. biochemi~, and functional pa_ rameters that predict the frequency of rejection episodes, the chance of sur-ivaI, and the cause of death. should death occur in these patients. The follo .... ;ng is a report of our findings. W( studlt'd all adult candidatn "ho "erc (\alu3tl'd for possiblt' !tvt'r transplantation bet"t'en Scptcmhcr 1984 and September 1986 During this period. I ~O adult patients rec(ived transplantations at the Uni\er..ity of PillSburgh ~inet) -eight of these patient~ had a protocol preoperati\e (valuation before the transplant and "'cre considered for inclusion 10 the stud~. The remaining ~~ patients were either (valuated at their own referring institutions or were sent directly to the surg.ical service (n :: 42) and were (ither not evaluated completely or had acute hepatic failure that prohibited a complete preoperative evaluation (n = 10) before transplantation.
The indicator.. of need for Ol Tx in these 98 patients are shown in Table I . Overall, we can divide these 98 patients into three distinct groups: a parenchymal liver disease group (PlD, n = 43), a cholestatic liver disease group (ChLD. n = 45), and a miscellaneous group (MISe. n = 10). The mean ± SEM age for the PLD patients was 33 ± 2 years (range = 17-59 yrs): 40 ± 2 years for the ChlD patients (range = 20-57 yrs); and 40 ± 4 years for the MISe (range = 21-52 yrs). The ratio of men to women was 1.3 for the PlD group, 0.7 for the ChLD group, and 1.2 for the MISe group.
The average interval between the initial evaluation and the subsequent OL Tx was 4 months (rang.e = I week-I year); the average for patients with PlD. 3.0 ± 0.6 months, was shorter than it was for patients "'ith ChlD, for whom it was 5.0 ± 0.6 months (p < 0.05).
The following biochemical and immunological parameters were determined for all candidates: serum bilirubin and albumin levels. prothrombin time (PT), total lymphoC)1e count and lymphoc)1e subsets determinations. and the patient's histocompatibility antigens (HLA). Both absolute numbers and the percentage of T Jymphoc,)1es and the various T lymphoc)1e subsets were determined The T cell subpopulations were determined by flow cytometf') on a FACS IV (Becton-DiclOnson. Mountain View. CAl, using a slight modification of the method described pre\;ously.' The follo",;ng fluorescent labeled anti-T cell surface marker monoclonal antibodies were used: T3 (OKT). Ltu 4), T. (OKT •. Ltu 3 a + b). and T. (OKT,. Ltu 2a). (The OKT series was purchased from Ortho Diagnostics; the Ltu series was purchased from Becton-Dick.in~n.) At least 5 X 10' cells were analyzed for each monoclonal antibody determination. Control lymphocyte subset measurements were obtained in 100 contemporarily studied. normal patients.
In 80 of the 98 patients studied. peripheral blood lymphocytes of both the donor and the recipient were typed for HLA A. B. and DR antigens. The method used included the use of the standard National Institute of Health microlymphoc)10toxicity technique for detec- tion of A and B antigens and prolonged incubation microlymphoc)10xicity testing using enriched B<ell pre~ arations obtained after carbonyl·iron treatment and Ficol\·H Hypaque sedimentation after rosetting with neuraminidase-treated sheep red blood cells for the detection of the DR antigens. HLA matching between donors and recipients was considered when an antigen present in the donor was also present in the recipient. Measurement of the plasma retention of Jndoc)anine green (ICG) at 15 minutes and its plasma disappearance rate. obtained after intravenous (l.V.) administration of the drug. were determined in 86 of the patients The follo,,;ng parameters were studied after OL Tx: survival. cause of death. number of rejection episodes. hospitalization duration. the cyclosporine and prednisone dose (oral) given at discharge. and the last followup cyclosporine and predni~ne dosage.
In regard to sun;val. five groups of patients were con· sidered. Group A (n = 13) included patients dying during the first 6 postoperative weeks; Group B (n = II) consisted of those d)ing between the 6th and 12th postoperative weeks; Group C (n = 3) consisted of those who died after the 12th postoperative week; Group D (n = 39) included patients who sun;ved after a follow-up less of than I year. and Group E (n = 31) included patients who sun;ved after .. follow-up of more than I year. Two other patient categories were al~ evaluated: the 24 patients who died within 12 weeks of the transplantation procedure (Groups A and B combined) and the 70 patients who survived at least 12 weeks after the operation (Groups 0 and E combined).
A rejection episode was considered present when an elevation of bilirubin and/or gamma gJutamyl transpeptidase occurred in the absence of biliary obstruction. or vascular thrombosis and resolved rapidly ~;th the initiation of antirejection therapy. Histologic confirmation of
Opcratl"e n Before Ol Tx, aaforin (I g of IV) was given to all patients. Ampicillin (I g) and claforin (I g) were given intravenously every 6 hours for 5 days; Mycostatin was given orally at identical intenals.
Twenty-seven patients died. A complete autops~ was obtained from 22. Generall), either the most prominent pathologic eV'ent found at the time of the autops) or if an autopsy was not performed, the most important compli~tion during the immediate preterminal clinical course was identified as the cause of death.
Pre-and postoperative <Uta were entered in on an IBM"" computer. Analysis of variance (ANOV A), Spearman correlation, chi-square analysis, and Student's I test for paired and unpaired values were used in the statistical analysis of the <Uta obtained using a Statpack"'. Statistical significance was obtained when the p value was at least <0.05.
Rc-sults

Sun';}'a!
The survival groups are represented in Table 2 as well as cause of death, the cause of sepsis, number of retransplantation when it occurred, and the ratio of PlD/ ChlO cases for each group. Thirteen per cent (13 of 98 patients) of the deaths observed occurred v.ithin 6 weeks of operation; 24~ (24 of 98 patients) occurred within 12 weeks of the procedure. Only 3% (three of 97 patients) of the deaths occur more than 12 weeks after the time of surgery. Sepsis was the principle cause (79S"c: 19 of 24 patients) of death in those who died v.ithin 12 weeks of surgery. Bacterial and fungal sepsi~ was seen as the cause of death principall) in those patients who died v.ithin the first 6 weeks, whereas viral and protozoal sepsis were the principal causes of death that ()(Xurred after 6 weeks (X 2 = 6.6; 95% Confidence Interval (Cl) 2.1-121.3; p < 0.0 I). An odds ratio for deaths of 16.33 was obtained, shov.ing that risk of earl) death (before 6 weeks) was increased sixteen-fold in those who de\eJoped an earl) postoperative bacterial and fungal infection.
A higher frequenC) of retransplantation was seen in Groups A and B as compared to Groups 0 and E (14 of 24 patients = 58~ l'S 10 of 70 patients = 14~, P < 0.05) Interestingly, the PLD/ChlO ratio was higher in the Group A patients who died of early bacterial or fungal sepsis as compared to any of the other four groups (X: = 5.1; 95~ CII.13-32.7; p < 0.05).
The percentage of patients operated upon for PlO, ChLD and MISe hepatic diseases who sun;ved at 6 weeks, 12 weeks. and I year is shown in Figure I . There was a rapid decline in patient survival in the PlO group during the first 6 postoperative weeks as compared to either of the other two patient groups. Overall, the percentage of patients who survived at any point was bener for those in either the MISC or the ChLO categories than it was for those in the PlO group. Of particular interest, however, is the fact that after the initial 6 weeks. the survival curves for all three groups were essentially parallel (Fig. 1) . "·l';, 41 H,,,, ';t'1I;/II)I and lu",·   11,''1.1,'1.'11'11.1:1" None of these parameters was significantly different between the two groups. The lCG disappearance curves for these two groups of patients is shown in Figure 2 and is compared to that of normal controls.
llsing analysis of variance. the same parameters 'Mre evaluated in the fi.;e sun'ival groups Again. there were no statisticall~ significant differences bet"een the dIffer· ent survival groups.
The degree ofHLA·A and B (Class I • SlJlIIstlcall~ dlffcrtnl (II lusl P < OO~) fron-. PlD 1 St.allstlCall~ different (it Ic.ast p < OO~ I from controh ~ 100 control p.1l1enu .... ere sludled for compamon of the tmmunoobtained between the number of lymphoc~1es or the number of various lymphoc~1e subsets and the number of rejection episodes experienced. the last hospitalization dosage of CyA and prednisone. the last follow-up dosage ofCyA and prednisone or the duration ofhospitalization. Moreover, the number of rejection episodes did not differ between the various suni\al groups (Mean ± SEM: I ± 0.4 in Group A; I ± 0.4 in Group 8; 0.3 ± 0.3 in Group C; L7 ± 0.3 in Group 0; 1.2 ± 0,2 in Group E).
Discussion
In this stud), we tried to identif) the pretransplantation-obtained immunological, biochemical and functional parameters the might be of help in predicti ng the ultimate outcome of the procedure. Onl) those parameters that could be obtained as part of a systematic routine pretransplant work-up were considered for evaluation. It has been ShO .... l1 that patients .... ith hepatic failure due to any cause severe enough to warrant }j\er trans· plantation have abnormalities in the number and percentage of cells in each of the various mononuclear cell subsets As far as ~lIular immunit~ parameters are concerned, patients with ChLD as compared to normal controls and patients .... ith PLD have significantl~ higher pretransplant helper-suppressor ratios. primaril~ be· planl HlA malches "'llh donor (mean:! SEM) (n " 82) of p0sl()perall\e deaths occumn~ in palients with PLD v.lthln the fl~1 f. postoperalj\e w{'eh O\erall. mortaht~ in the presenl s(f"ie~ was 27~ (27 of 9g patients). most of which occurred during the fi~t I ~ postoperati\e v.eeks It should also be emphasized that among Ihe Group A pallents (those dying within 6 weeks of operation). tWice as man~ patients had PLO as had ChLO. v. hereas a ratio of less than one was present in the four other survival groups Moreover. bacterial. and fungal sepsis were the two major causes of death In the Group A patients.
It is not unreasonable to think that the mechanisms responsible for protecting the indhidual against bacterial infection that are particularly deficient in patients with advanced PlO as compared to ClO normalize with the successful engraflment of a functioning liver.
However. as graft dysfunction frequently persists. at least to some degree. during the first 2 postoperative weeks, it is also probable that any pre-existing abnormality in host defense mechanisms will persist or become even less effective for a short period after Ol Tx. thereby rendering the patient even more susceptible to' bacterial and/or fungal sepsis. Because it has been shown to influence cellular immune response mecha· nisms. 9tO poor nutrition could also be implicated and could aggravate a pre-existing reduction in helper cell function present in liver transplant patients. occurring as a consequence of either their primary hepatic disease or the immunosuppression therapy that the)' reQuire.
The fact that a reduced serum albumin level is related to greater blood losses experienced during the first phase (dissection) of OL T). procedure l' and that the preopera· tive coagulation profile is more severely altered in patients v.ith PLO than it is in patients .... ith ChLD. ,; is consistent also v.ith the observation of a greater postoperative mortalit:-in patients .... ith parenchymal liver disease than those .... ith cholestatic liver disease. It remains to be shown howe\er that the preoperative correction of preexisting nutritional abnormalities present in PlO patients improves the survlval of these patients follo .... ing OlTx. Unfortunately, immunological biochemical and functional parameters of liver function obtained before
'''8it ~ ((lnir~PI\ 0-; 8,·· ... (.·,. /.: . . ·1(1(; \ " . .. r,,\,,'\o": should be pointed out that the deaths that occuned afler the initial 6 weeks occurred primarily as a result of a viral or protozoal infection and are. most like!). a consequence of the immunosuppression used. rather than a conseQuence of some pre-existlOg biological or immunological \'ariable determined before surgery that ma~ exist in the stud~ population. Ho",e\er. despite hov. dissatisfying the present data are. the~ do identif~ paramete~ that do not appear to be involved in determlTling sUl"\ival after OL h-that is. the number of rejection episodes andlor the number of HLA mismatches This is true despite the facl that it IS generall~ held that the HlA antigens of Class ) (A.. B) and Class 11 (DR) loci are thOUght to be strong transplantation antigens and to play an important role in the initiation of the rejection process.
A recent publication on more than 8000 kidne) transplant procedures collected from allover the world documents the relationship between sUl"\ival and the Considering all of the data a\ailable. the present stud) highlights the overall good results experienced with Ol T>. for end-stage liver disea!){' and (ontributes to the gro\l,lng confidence in pursuing liver tram-plantation as the treatment of choice for a variety of h\er dIseases v.ith irreversible advanced hepatic failure.
